Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy

• Mudasir Nabi Peerzada,
• Parvez Khan,
• Nashrah Sharif Khan,
• Fernando Avecilla,
• Shadab Miyan Siddiqui,
• Md. Imtaiyaz Hassan,
• Amir Azam

Affiliations

Mudasir Nabi Peerzada

Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, New Delhi, India

Parvez Khan

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

Nashrah Sharif Khan

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

Fernando Avecilla

Grupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Química, Facultade de Ciencias, Universidade da Coruña, A Coruña, Spain

Shadab Miyan Siddiqui

Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, New Delhi, India

Md. Imtaiyaz Hassan

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

Amir Azam

Medicinal Chemistry Research Laboratory, Department of Chemistry, Jamia Millia Islamia, New Delhi, India